–
Статьи в журналах
-
- 2016 A randomized, double-blind, placebo-controlled phase II study to assess the efficacy and safety of mapatumumab with sorafenib in patients with advanced hepatocellular carcinoma
- Ciuleanu, (Ciuleanu T., Bazin T.)., (Bazin I., Lungulescu I.)., (Lungulescu D., Miron D.)., (Miron L., Bondarenko L.)., (Bondarenko I., Deptala I.)., (Deptala A., Rodriguez-Torres A.)., (Rodriguez-Torres M., Giantonio M.)., (Giantonio B., Fox B.)., (Fox N.L., Wissel N.L.), (Wissel P., ) P.
- в журнале Annals of Oncology, издательство Oxford University Press (United Kingdom), том 27, № 4, с. 680-686 DOI